Lewandowski, K.; Kaniewska, M.; Tulewicz-Marti, E.; Głuszek-Osuch, M.; Ciechanowicz, P.; Walecka, I.; Rydzewska, G.
Should the Dermatological Assessment of Patients with Inflammatory Bowel Disease Become Standard during Qualifications for Biological Treatment? A Retrospective, Single-Center Experience from a Tertiary Center. J. Clin. Med. 2024, 13, 5213.
https://doi.org/10.3390/jcm13175213
AMA Style
Lewandowski K, Kaniewska M, Tulewicz-Marti E, Głuszek-Osuch M, Ciechanowicz P, Walecka I, Rydzewska G.
Should the Dermatological Assessment of Patients with Inflammatory Bowel Disease Become Standard during Qualifications for Biological Treatment? A Retrospective, Single-Center Experience from a Tertiary Center. Journal of Clinical Medicine. 2024; 13(17):5213.
https://doi.org/10.3390/jcm13175213
Chicago/Turabian Style
Lewandowski, Konrad, Magdalena Kaniewska, Edyta Tulewicz-Marti, Martyna Głuszek-Osuch, Piotr Ciechanowicz, Irena Walecka, and Grażyna Rydzewska.
2024. "Should the Dermatological Assessment of Patients with Inflammatory Bowel Disease Become Standard during Qualifications for Biological Treatment? A Retrospective, Single-Center Experience from a Tertiary Center" Journal of Clinical Medicine 13, no. 17: 5213.
https://doi.org/10.3390/jcm13175213
APA Style
Lewandowski, K., Kaniewska, M., Tulewicz-Marti, E., Głuszek-Osuch, M., Ciechanowicz, P., Walecka, I., & Rydzewska, G.
(2024). Should the Dermatological Assessment of Patients with Inflammatory Bowel Disease Become Standard during Qualifications for Biological Treatment? A Retrospective, Single-Center Experience from a Tertiary Center. Journal of Clinical Medicine, 13(17), 5213.
https://doi.org/10.3390/jcm13175213
